Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC47067 Luvadaxistat
TAK-831 is a highly selective and potent inhibitor of D-amino acid oxidase (DAAO) and can be used in studies of schizophrenia.
More description
DC47065 Idetrexed
Idetrexed is a thymidylate synthase inhibitor specifically transported into alpha-folate receptor (alpha-FR)-overexpressing tumors. BGC 945 inhibited thymidylate synthase with a Ki of 1.2 nmol/L.
More description
DC47064 Hexasodium phytate
Hexasodium phytate (Phytic acid hexasodium) is a phosphorus storage compound of seeds and cereal grains. Hexasodium phytate has a strong ability to chelate multivalent metal ions, specially zinc, calcium, iron and as with protein residue. Hexasodium phytate inhibits the enzymatic superoxide source xanthine oxidase (XO), and has antioxidative, neuroprotective, anti-inflammatory effects.
More description
DC47061 ARN 077 (enantiomer)
ARN 077 enantiomer (19) is the less active enantiomer of ARN 077, with an IC50 of 3.53 μM for rat NAAA.
More description
DC47047 Polθ-IN-1-d3
Polθ-IN-1-d3 (example 1) is a deuterated Polθ inhibitor used for cancer study (extracted from patent WO2021028670).
More description
DC47028 Sec61-IN-3
Sec61-IN-2 (A3) is a protein secretion inhibitor (extracted from patent WO2020176863).
More description
DC47027 Ezurpimtrostat
Ezurpimtrostat (compound 2-2) is used for the study of fibrosis, cancer, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases (extracted from patent WO2020048694 A1).
More description
DC47026 4-Phenyl-7,8-dihydroxycoumarin
4-Phenyl-7,8-dihydroxycoumarin is a coumarin derivative and can be used for bronchiectasiss research.
More description
DC47024 Ivospemin
Ivospemin is an antineoplastic spermine analog.
More description
DC47023 Lenalidomide-C10-OH
Lenalidomide-C10-OH (6a) is an intermediate in the synthesis of INY-03-041.
More description
DC47022 Quercetin 3,3'-dimethyl ether
Quercetin 3,3'-dimethyl ether possesses antioxidant acticity.
More description
DC47021 Sec61-IN-2
Sec61-IN-2 (A347) is a protein secretion inhibitor (extracted from patent WO2020176863).
More description
DC47020 Sophoramine
Sophoramine ((-)-Sophoramine), an alkaloid, is a dehydro-derivative of Matrine.
More description
DC47019 Sucunamostat
Sucunamostat is an L-aspartic acid enteropeptidase inhibitor.
More description
DC47016 Yadanzioside M
Yadanzioside M is a natural compound with anti-cancer activity.
More description
DC47015 D-(+)-Fucose
D-(+)-Fucose is a nonmetabolizable analogue of l-arabinose. D-(+)-Fucose prevents growth of Escherichia coli B/r on a mineral salts medium plus l-arabinose by inhibiting induction of the l-arabinose operon. D-fucose is a potent inducer of beta-methylgalactoside permease (MGP).
More description
DC47012 Valethamate bromide
Valethamate bromide is an ester and is a potent rapidly acting anticholinergic spasmolytic and musculotropic agent which accelerates labor by improving cervical dilation.
More description
DC47010 Astragenol
Astragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research.
More description
DC47007 3,3'-Diethyloxacarbocyanine iodide
3,3'-Diethyloxacarbocyanine iodide is a microviscosity probe for micelles and microemulsions.
More description
DC47005 Ludaterone
Ludaterone is an antiandrogen agent, with potent antiandrogenic activity.
More description
DC46998 (R)-BAY-899
(R)-BAY-899 is the R-enantiomer of BAY-899. BAY-899 is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively.
More description
DC46997 Guraxetan
Guraxetan can be used for the synthesis of antineoplastic lutetium (177Lu) zadavotide Guraxetan.
More description
DC46995 Kisspeptin-10, rat TFA
Kisspeptin-10, rat TFA is a potent vasoconstrictor and inhibitor of angiogenesis. Kisspeptin-10, rat TFA is a ligand for the rodent kisspeptin receptor (KISS1, GPR54). Kisspeptin-10 TFA reduces Methotrexate-induced reproductive toxicity as a potential antioxidant compound.
More description
DC46994 Uty HY Peptide (246-254) (TFA)
Uty HY Peptide (246-254) TFA, derived from the ubiquitously transcribed tetratricopeptide repeat gene on the Y chromosome (UTY) protein as an H-Y epitope, H-YDb, is a male-specific transplantation antigen H-Y.
More description
DC46993 Thioacetamide
Thioacetamide (TAA) is a hepatotoxin frequently used for experimental purposes which produces centrilobular necrosis after a single dose administration.
More description
DC46992 Simethicone
Simethicone (Simeticone) is a nonabsorbable, surface-active, antifoaming agent.
More description
DC46991 PKG inhibitor peptide
PKG inhibitor peptide is an ATP-competitive inhibitor of cGMP-dependent protein kinase (PKG), with a Ki of 86 μM.
More description
DC46990 JAG-1, scrambled TFA
JAG-1, scrambled (scJag-1) TFA is a scrambled sequence of JAG-1 (Jagged-1 protein). JAG-1, scrambled TFA has a random sequence of the amino acids that are the same as the active fragment. JAG-1, scrambled TFA is usually used as a negative control.
More description
DC46988 Imeglimin (EMD 387008) Hydrochloride
Imeglimin (EMD 387008, IMEG, PXL 008, RVT-1501) Hydrochloride is a new class of oral glucose-lowering agents. Imeglimin normalizes glucose tolerance and insulin sensitivity by preserving mitochondrial function from oxidative stress and favoring lipid oxidation in liver of HFHSD mice.
More description
DC46987 N-Nitroso-N-methylurea
N-Nitroso-N-methylurea (NMU, MNU, NMH, 1-Methyl-1-nitrosourea, N-Methyl-Nnitrosourea, Methylnitrosourea) is a highly reliable carcinogen, mutagen, and teratogen.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X